DrugCite

Alaway and Disturbance In Attention

This page shows results related to Alaway and Disturbance In Attention from the FDA Adverse Event Reporting System (AERS). The adverse event Disturbance In Attention has been reported to the FDA a total of 1 times for Alaway.

Learn More About Alaway Adverse Events

Safety Comparison of Disturbance In Attention in Alaway and Related Drugs

The Proportional Reporting Ratio (PRR) for Alaway and Disturbance In Attention is 1. The chart below compares this proportional reporting ratio of Disturbance In Attention for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Disturbance In Attention.

Disturbance In Attention
Alaway
1

NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.

People Reporting Disturbance In Attention Used Alaway For the Following Reasons

Of those reporting Disturbance In Attention, why were they taking Alaway?

Eye Pruritus
1


Scientific Publications on Disturbance In Attention

Powered by Google